Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boudewijn Brans

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2007
EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseasesJan Tennvall, Boudewijn Brans
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2011
90Y/177Lu-DOTATATE therapy: survival of the fittest?Boudewijn Brans, Felix M Mottaghy, Alfons Kessels
Methods (San Diego, Calif.)|June 28, 2011
Molecular nuclear therapies for thyroid carcinomaFrederik A Verburg, Boudewijn Brans, Felix M Mottaghy
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2008
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapyFrancesco Giammarile, Arturo Chiti, Michael Lassmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2006
Clinical applications of newer radionuclide therapiesBoudewijn Brans, Ola Linden, Francesco Giammarile, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scansMyriam Monsieurs, Boudewijn Brans, Klaus Bacher, et al.
Nuclear Medicine Communications|June 24, 2010
Comparison of sentinel gamma probes for 99mTc breast cancer surgery based on NEMA NU3-2004 standardMariangela Zamburlini, Kristien Keymeulen, Marc Bemelmans, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
¹²⁴I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy ¹³¹I SPECT/CTCecile de Pont, Servais Halders, Jan Bucerius, et al.
Clinical Nuclear Medicine|July 3, 2013
18F-fluoride PET/CT scan for quantification of bone metabolism in the inner ear in patients with otosclerosis--a pilot studyJérôme J Waterval, Maud Vallinga, Boudewijn Brans, et al.
Skeletal Radiology|March 11, 2014
Comparison of [18 F]FDG PET/CT and MRI in the diagnosis of active osteomyelitisAnastas Demirev, René Weijers, Jan Geurts, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2007
EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseasesJan Tennvall, Boudewijn Brans
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2011
90Y/177Lu-DOTATATE therapy: survival of the fittest?Boudewijn Brans, Felix M Mottaghy, Alfons Kessels
Methods (San Diego, Calif.)|June 28, 2011
Molecular nuclear therapies for thyroid carcinomaFrederik A Verburg, Boudewijn Brans, Felix M Mottaghy
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2008
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapyFrancesco Giammarile, Arturo Chiti, Michael Lassmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2006
Clinical applications of newer radionuclide therapiesBoudewijn Brans, Ola Linden, Francesco Giammarile, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scansMyriam Monsieurs, Boudewijn Brans, Klaus Bacher, et al.
Nuclear Medicine Communications|June 24, 2010
Comparison of sentinel gamma probes for 99mTc breast cancer surgery based on NEMA NU3-2004 standardMariangela Zamburlini, Kristien Keymeulen, Marc Bemelmans, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
¹²⁴I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy ¹³¹I SPECT/CTCecile de Pont, Servais Halders, Jan Bucerius, et al.
Clinical Nuclear Medicine|July 3, 2013
18F-fluoride PET/CT scan for quantification of bone metabolism in the inner ear in patients with otosclerosis--a pilot studyJérôme J Waterval, Maud Vallinga, Boudewijn Brans, et al.
Skeletal Radiology|March 11, 2014
Comparison of [18 F]FDG PET/CT and MRI in the diagnosis of active osteomyelitisAnastas Demirev, René Weijers, Jan Geurts, et al.
Pageof 7